Chang CM - Search Results

1

Mechanism of CDK4/6 Inhibitor Resistance in Hormone Receptor-positive Breast Cancer and Alternative Treatment Strategies.

Chang CM, Lam HYP. Chang CM, et al. Anticancer Res. 2023 Dec;43(12):5283-5298. doi: 10.21873/anticanres.16732. Anticancer Res. 2023. PMID: 38030174 Review.

2

Therapeutic Peptide RF16 Derived from CXCL8 Inhibits MDA-MB-231 Cell Invasion and Metastasis.

Chang CM, Chang CC, Lam HYP, Peng SY, Lai YH, Hsiang BD, Liao YY, Hsu HJ, Jiang SJ. Chang CM, et al. Among authors: chang cc. Int J Mol Sci. 2023 Sep 13;24(18):14029. doi: 10.3390/ijms241814029. Int J Mol Sci. 2023. PMID: 37762330 Free PMC article.

3

Metaplastic Carcinoma of the Axillary Breast With Heterologous Mesenchymal (Chondroid) Differentiation: A Difficult Case and Literature Review.

Chang CM, Lam HYP. Chang CM, et al. Breast Cancer (Auckl). 2023 Nov 24;17:11782234231215183. doi: 10.1177/11782234231215183. eCollection 2023. Breast Cancer (Auckl). 2023. PMID: 38024140 Free PMC article.

4

The Use of Schisandrin B to Combat Triple-Negative Breast Cancers by Inhibiting NLRP3-Induced Interleukin-1β Production.

Chang CM, Liang TR, Lam HYP. Chang CM, et al. Biomolecules. 2024 Jan 5;14(1):74. doi: 10.3390/biom14010074. Biomolecules. 2024. PMID: 38254674 Free PMC article.

5

Risk of breast cancer in women with non-lactational mastitis.

Chang CM, Lin MC, Yin WY. Chang CM, et al. Sci Rep. 2019 Oct 30;9(1):15587. doi: 10.1038/s41598-019-52046-3. Sci Rep. 2019. PMID: 31666573 Free PMC article.

6

Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care.

Wu CC, Hsu TW, Chang CM, Lee CH, Huang CY, Lee CC. Wu CC, et al. Among authors: chang cm. Oncologist. 2016 Jun;21(6):771-7. doi: 10.1634/theoncologist.2015-0445. Epub 2016 Apr 18. Oncologist. 2016. PMID: 27091417 Free PMC article.

7

The association of socioeconomic status and access to low-volume service providers in breast cancer.

Chang CM, Yin WY, Wei CK, Lin CH, Huang KY, Lin SP, Lee CH, Chou P, Lee CC. Chang CM, et al. PLoS One. 2013 Dec 2;8(12):e81801. doi: 10.1371/journal.pone.0081801. eCollection 2013. PLoS One. 2013. PMID: 24312589 Free PMC article.

8

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial.

Chen LC, Chiou WY, Lin HY, Lee MS, Lo YC, Huang LW, Chang CM, Hung TH, Lin CW, Tseng KC, Liu DW, Hsu FC, Hung SK. Chen LC, et al. Among authors: chang cm. BMC Cancer. 2019 Mar 28;19(1):275. doi: 10.1186/s12885-019-5461-3. BMC Cancer. 2019. PMID: 30922261 Free PMC article. Clinical Trial.

9

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer.

Wu CC, Fang CY, Yu BH, Chang CM, Hsu TW, Hung CL, Hung SK, Chiou WY, Tsai JH. Wu CC, et al. Among authors: chang cm. Cancers (Basel). 2023 Nov 6;15(21):5304. doi: 10.3390/cancers15215304. Cancers (Basel). 2023. PMID: 37958477 Free PMC article.

10

The combined effect of individual and neighborhood socioeconomic status on cancer survival rates.

Chang CM, Su YC, Lai NS, Huang KY, Chien SH, Chang YH, Lian WC, Hsu TW, Lee CC. Chang CM, et al. Among authors: chang yh. PLoS One. 2012;7(8):e44325. doi: 10.1371/journal.pone.0044325. Epub 2012 Aug 30. PLoS One. 2012. PMID: 22957007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,166 results

Search Page